MANILA, Philippines — The Food and Drug Administration (FDA) is now reviewing the application of American pharmaceutical company Moderna Inc. for an emergency use authorization (EUA) of its COVID-19 vaccine.
FDA Director General Eric Domingo confirmed in a text message to INQUIRER.net on Tuesday that Moderna has applied for a EUA on Monday.
Domingo added that it is “still being checked” if Moderna has submitted complete documents for its application.
The FDA earlier approved the emergency use in the Philippines of COVID-19 vaccines from Pfizer-BioNTech, AstraZeneca, Sinovac Biotech, Gamaleya Institute, Janssen, and Bharat B…
Keep on reading: FDA reviewing Moderna’s COVID-19 vaccine EUA application